Inspire Medical Systems, Inc. (NYSE:INSP) Shares Purchased by BNP Paribas Financial Markets

BNP Paribas Financial Markets grew its stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 99.7% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 4,711 shares of the company’s stock after purchasing an additional 2,352 shares during the quarter. BNP Paribas Financial Markets’ holdings in Inspire Medical Systems were worth $994,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the stock. Bank of New York Mellon Corp increased its holdings in shares of Inspire Medical Systems by 32.3% during the second quarter. Bank of New York Mellon Corp now owns 787,815 shares of the company’s stock valued at $105,433,000 after acquiring an additional 192,238 shares in the last quarter. William Blair Investment Management LLC increased its holdings in Inspire Medical Systems by 1.8% in the 2nd quarter. William Blair Investment Management LLC now owns 770,413 shares of the company’s stock worth $103,104,000 after buying an additional 13,602 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in Inspire Medical Systems by 4.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 281,165 shares of the company’s stock worth $59,340,000 after buying an additional 11,939 shares during the period. Allspring Global Investments Holdings LLC increased its holdings in Inspire Medical Systems by 798.3% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 267,852 shares of the company’s stock worth $56,530,000 after buying an additional 238,034 shares during the period. Finally, Eagle Asset Management Inc. increased its holdings in Inspire Medical Systems by 82.4% in the 3rd quarter. Eagle Asset Management Inc. now owns 260,753 shares of the company’s stock worth $51,269,000 after buying an additional 117,819 shares during the period. Institutional investors and hedge funds own 94.91% of the company’s stock.

Analysts Set New Price Targets

INSP has been the topic of several research reports. Stifel Nicolaus reiterated a “hold” rating and issued a $200.00 price target (up previously from $170.00) on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Bank of America upgraded shares of Inspire Medical Systems from a “neutral” rating to a “buy” rating and increased their price target for the stock from $220.00 to $255.00 in a report on Wednesday, November 20th. Wells Fargo & Company increased their price target on shares of Inspire Medical Systems from $187.00 to $198.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 5th. Truist Financial reiterated a “buy” rating and issued a $240.00 price target (up previously from $217.00) on shares of Inspire Medical Systems in a report on Monday, September 30th. Finally, Robert W. Baird upped their price objective on Inspire Medical Systems from $240.00 to $252.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 5th. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $233.58.

Inspire Medical Systems Trading Up 0.0 %

Inspire Medical Systems stock opened at $189.59 on Wednesday. Inspire Medical Systems, Inc. has a 12 month low of $123.00 and a 12 month high of $257.40. The firm has a market cap of $5.68 billion, a PE ratio of 177.03 and a beta of 1.31. The stock’s 50 day simple moving average is $195.93 and its two-hundred day simple moving average is $177.95.

Inspire Medical Systems (NYSE:INSP) last announced its earnings results on Monday, November 4th. The company reported $0.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.06 by $0.54. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. The firm had revenue of $203.20 million for the quarter, compared to analyst estimates of $197.59 million. During the same quarter last year, the firm posted ($0.29) EPS. The business’s revenue was up 32.6% on a year-over-year basis. On average, equities research analysts forecast that Inspire Medical Systems, Inc. will post 1.33 EPS for the current year.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.